ID24521A - USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT - Google Patents

USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT

Info

Publication number
ID24521A
ID24521A IDW20000669A ID20000669A ID24521A ID 24521 A ID24521 A ID 24521A ID W20000669 A IDW20000669 A ID W20000669A ID 20000669 A ID20000669 A ID 20000669A ID 24521 A ID24521 A ID 24521A
Authority
ID
Indonesia
Prior art keywords
tiazolidindion
hyperglicemia
treatment
hyperglicemia treatment
Prior art date
Application number
IDW20000669A
Other languages
Indonesian (id)
Inventor
Robin Edwin Buckingham
Stephen Alistair Smith
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ID24521A publication Critical patent/ID24521A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IDW20000669A 1997-10-13 1998-10-12 USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT ID24521A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment

Publications (1)

Publication Number Publication Date
ID24521A true ID24521A (en) 2000-07-20

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20000669A ID24521A (en) 1997-10-13 1998-10-12 USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT

Country Status (24)

Country Link
EP (1) EP1023056A1 (en)
JP (1) JP2001519382A (en)
KR (1) KR20010024481A (en)
CN (1) CN1281359A (en)
AP (1) AP2000001787A0 (en)
AU (1) AU9547098A (en)
BG (1) BG104404A (en)
BR (1) BR9815219A (en)
CA (1) CA2306086A1 (en)
CZ (1) CZ20001297A3 (en)
EA (1) EA002659B1 (en)
GB (1) GB9721693D0 (en)
HR (1) HRP20000255A2 (en)
HU (1) HUP0003922A3 (en)
ID (1) ID24521A (en)
IL (1) IL135513A0 (en)
NO (1) NO20001898L (en)
NZ (1) NZ503862A (en)
OA (1) OA11683A (en)
PL (1) PL339813A1 (en)
SK (1) SK5312000A3 (en)
TR (1) TR200000958T2 (en)
WO (1) WO1999018943A1 (en)
YU (1) YU28800A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7045519B2 (en) 1998-06-19 2006-05-16 Chiron Corporation Inhibitors of glycogen synthase kinase 3

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG59988A1 (en) * 1987-09-04 1999-02-22 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
IL135513A0 (en) 2001-05-20
PL339813A1 (en) 2001-01-02
NO20001898L (en) 2000-06-09
CN1281359A (en) 2001-01-24
NO20001898D0 (en) 2000-04-12
EP1023056A1 (en) 2000-08-02
YU28800A (en) 2003-02-28
EA002659B1 (en) 2002-08-29
BR9815219A (en) 2001-01-02
AP2000001787A0 (en) 2000-06-30
CA2306086A1 (en) 1999-04-22
JP2001519382A (en) 2001-10-23
CZ20001297A3 (en) 2001-08-15
HRP20000255A2 (en) 2001-02-28
TR200000958T2 (en) 2000-08-21
SK5312000A3 (en) 2000-09-12
KR20010024481A (en) 2001-03-26
NZ503862A (en) 2003-01-31
BG104404A (en) 2000-12-29
GB9721693D0 (en) 1997-12-10
WO1999018943A1 (en) 1999-04-22
HUP0003922A3 (en) 2001-12-28
EA200000419A1 (en) 2000-10-30
AU9547098A (en) 1999-05-03
HUP0003922A2 (en) 2001-10-28
OA11683A (en) 2005-01-12

Similar Documents

Publication Publication Date Title
PT1032396E (en) STERILIZATION OF GLUCOCORTICOESTEROIDS
NO983266D0 (en) Distributed Treatment
DK0951447T3 (en) water Treatment
NO992806L (en) Therapeutic agents
DE69524138D1 (en) Skin treatment agents
ID18679A (en) USE OF FURTHER THERAPY
NO20003065L (en) Combination for effective treatment of impotence
EP0996433A4 (en) TREATMENT PROCEDURE OF LACTOSYLCERAMIDE-CONDITIONED STATES
DE69807225D1 (en) Nonwoven TREATMENT
DE69833493D1 (en) TISSUE
ID21948A (en) USE OF 1-HYDROXY-2-PYRIDON FOR TREATMENT OF SKIN INFECTIONS
ID27214A (en) TRIAZOLOPIRIDINA FOR TREATMENT OF TROMBOSIS DISORDERS
IS4789A (en) treatment Compounds
NO983263L (en) Distributed treatment
ID24270A (en) REMOVAL OF KERATOTIC CONSTITIONS
ID23437A (en) REMOVAL OF KERATOTIC CONSTITIONS
ID24922A (en) COMBINATION THERAPY FOR TREATMENT OF AIDS
ATE235494T1 (en) IMINO-AZA ANTHRACYCLONE DERIVATIVES FOR THE TREATMENT OF AMYLOIDOSIS
ID24439A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
DE69812879D1 (en) PATIENTS LIEGE
ID24521A (en) USE OF TIAZOLIDINDION FOR HYPERGLICEMIA TREATMENT
ID17383A (en) LATEST USE OF SISTINA DOWN
NO20000274D0 (en) Treatment of fluids
ID29414A (en) TREATMENT OF DEPRESSION
ID17459A (en) ELEMENTS OF TREATMENT